Results 111 to 120 of about 8,420 (208)

Antihypertensive efficacy of olmesartan medoxomil and candesartan cilexetil assessed by 24-hour ambulatory blood pressure monitoring in patients with essential hypertension.

open access: yes, 2003
To compare the antihypertensive efficacy of olmesartan medoxomil with that of candesartan cilexetil after 1, 2 and 8 weeks of treatment. Randomised, double-blind, parallel-group study conducted at 44 centres in Germany, Poland and the Czech Republic. 643
Stumpe, K.O.   +8 more
core   +1 more source

Olmesartan/amlodipine: a review of its use in the management of hypertension

open access: yesVascular Health and Risk Management, 2011
R KreutzInstitute of Clinical Pharmacology and Toxicology, Charité, Universtitätsmedizin – Berlin, GermanyAbstract: Combination therapy is an effective strategy to increase antihypertensive efficacy in those patients with poor blood ...
Kreutz R
doaj  

Antihypertensive efficacy of olmesartan medoxomil and ramipril in elderly patients with mild to moderate hypertension grouped according to renal function status : a retrospective analysis.

open access: yes, 2012
Aim: The objective of this study was to compare the antihypertensive efficacy and safety of the angiotensin II antagonist olmesartan medoxomil and the ACE inhibitor ramipril in elderly patients with mild to moderate essential hypertension, grouped ...
S. Omboni   +4 more
core   +1 more source

Possible toxic effect of antihypertensive drug olmesartan on male reproductive system of rat [PDF]

open access: yes, 2017
Background: To evaluate the possible toxic effect of a new angiotensin II receptor antagonist or blocker, olmesartan medoxomil, on the male reproductive system of rat.Methods: Twelve Sprague Dawley rats, randomly divided into two groups: treated group (n=
Jayachandra, Srinivasa, Ng, AnnGie
core  

Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines

open access: yesClinical Interventions in Aging, 2015
Stefano Omboni,1 Ettore Malacco,2 Jean-Michel Mallion,3 Massimo Volpe4,5 1Clinical Research Unit, Italian Institute of Telemedicine, Solbiate Arno, Varese, Italy; 2Department of Internal Medicine, Ospedale L Sacco, University of Milan, Milan, Italy ...
Omboni S, Malacco E, Mallion JM, Volpe M
doaj  

A Review of Current Evidence of Olmesartan Medoxomil Mimicking Symptoms of Celiac Disease

open access: yes, 2014
Objective: To review the evidence of an association between olmesartan medoxomil and symptoms mimicking celiac disease. Data Sources: Literature was searched in PubMed (1965-November 2013) using the key words or MeSH terms olmesartan, enteropathy, celiac
Stanford, Michele L., Nagel, Angela
core   +1 more source

PROTECTIVE EFFECTS OF ANGIOTENSIN II BLOCKADE WITH OLMESARTAN MEDOXOMIL ON RESISTANCE VESSEL REMODELING

open access: yesРоссийский кардиологический журнал, 2010
The VIOS (Vascular Improvement with Olmesartan medoxomil Study) study is a randomized, parallel study to determine the relative effects of suppressing the renin-angiotensin system (RAS) with the angiotensin receptor antagonist olmesartan medoxomil versus
Ronald D. Smith   +6 more
doaj  

Home - About - Disclaimer - Privacy